Cardiff Oncology Inc
NASDAQ:CRDF
Income Statement
Earnings Waterfall
Cardiff Oncology Inc
Revenue
|
488k
USD
|
Operating Expenses
|
-45.9m
USD
|
Operating Income
|
-45.4m
USD
|
Other Expenses
|
3.9m
USD
|
Net Income
|
-41.5m
USD
|
Income Statement
Cardiff Oncology Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
0
-4%
|
0
+4%
|
0
+8%
|
0
N/A
|
0
+11%
|
0
-3%
|
0
N/A
|
0
+3%
|
0
N/A
|
0
+16%
|
0
+8%
|
0
-3%
|
0
-5%
|
0
N/A
|
0
+8%
|
1
+31%
|
1
N/A
|
1
+2%
|
0
-6%
|
0
-22%
|
0
-11%
|
0
-21%
|
0
-15%
|
0
+4%
|
0
+4%
|
0
N/A
|
0
+36%
|
0
+9%
|
0
N/A
|
0
+8%
|
0
-13%
|
0
+3%
|
0
N/A
|
0
+6%
|
0
N/A
|
0
+3%
|
0
N/A
|
0
+5%
|
0
+12%
|
0
+6%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-300%
|
(0)
-300%
|
(0)
-100%
|
(0)
-44%
|
(1)
-61%
|
(1)
-30%
|
(1)
-41%
|
(2)
-25%
|
(2)
+4%
|
(2)
-1%
|
(1)
+20%
|
(1)
+19%
|
(1)
+14%
|
(1)
+45%
|
(0)
+56%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+85%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(11)
|
(12)
|
(13)
|
(14)
|
(15)
|
(17)
|
(20)
|
(22)
|
(25)
|
(30)
|
(34)
|
(37)
|
(38)
|
(36)
|
(32)
|
(28)
|
(22)
|
(19)
|
(17)
|
(15)
|
(16)
|
(17)
|
(16)
|
(17)
|
(17)
|
(17)
|
(17)
|
(17)
|
(19)
|
(21)
|
(24)
|
(26)
|
(29)
|
(35)
|
(38)
|
(40)
|
(40)
|
(41)
|
(43)
|
(45)
|
(46)
|
|
Selling, General & Administrative |
(7)
|
(7)
|
(8)
|
(8)
|
(7)
|
(10)
|
(12)
|
(14)
|
(12)
|
(19)
|
(21)
|
(22)
|
(18)
|
(18)
|
(17)
|
(15)
|
(13)
|
(13)
|
(10)
|
(8)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(6)
|
(8)
|
(9)
|
(10)
|
(11)
|
(12)
|
(14)
|
(14)
|
(14)
|
(13)
|
(12)
|
(14)
|
(13)
|
(13)
|
|
Research & Development |
(4)
|
(4)
|
(5)
|
(6)
|
(8)
|
(7)
|
(8)
|
(8)
|
(13)
|
(12)
|
(13)
|
(14)
|
(20)
|
(18)
|
(15)
|
(13)
|
(9)
|
(6)
|
(7)
|
(7)
|
(8)
|
(9)
|
(10)
|
(11)
|
(11)
|
(11)
|
(11)
|
(11)
|
(11)
|
(12)
|
(13)
|
(15)
|
(17)
|
(21)
|
(25)
|
(26)
|
(27)
|
(29)
|
(30)
|
(32)
|
(33)
|
|
Operating Income |
(11)
N/A
|
(12)
-8%
|
(12)
-8%
|
(13)
-7%
|
(15)
-12%
|
(17)
-11%
|
(20)
-21%
|
(22)
-12%
|
(25)
-13%
|
(31)
-22%
|
(34)
-11%
|
(38)
-10%
|
(39)
-4%
|
(37)
+5%
|
(33)
+11%
|
(29)
+12%
|
(23)
+20%
|
(20)
+16%
|
(18)
+9%
|
(16)
+13%
|
(16)
-5%
|
(16)
+0%
|
(16)
+1%
|
(16)
-2%
|
(17)
-1%
|
(17)
-1%
|
(17)
+1%
|
(17)
-1%
|
(19)
-13%
|
(20)
-7%
|
(23)
-14%
|
(26)
-11%
|
(29)
-12%
|
(34)
-20%
|
(38)
-10%
|
(40)
-5%
|
(40)
+0%
|
(41)
-2%
|
(43)
-4%
|
(44)
-4%
|
(45)
-2%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(1)
|
(2)
|
3
|
3
|
1
|
(2)
|
(7)
|
(2)
|
(2)
|
0
|
4
|
(0)
|
1
|
1
|
1
|
3
|
3
|
2
|
4
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
2
|
2
|
3
|
4
|
4
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(3)
|
(4)
|
(4)
|
(4)
|
(2)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Pre-Tax Income |
(12)
N/A
|
(14)
-18%
|
(10)
+30%
|
(11)
-10%
|
(14)
-34%
|
(18)
-28%
|
(27)
-50%
|
(25)
+10%
|
(27)
-11%
|
(31)
-11%
|
(31)
0%
|
(38)
-24%
|
(39)
-3%
|
(39)
+1%
|
(37)
+6%
|
(31)
+16%
|
(25)
+19%
|
(20)
+21%
|
(15)
+22%
|
(15)
+3%
|
(16)
-11%
|
(16)
+5%
|
(16)
-2%
|
(16)
-2%
|
(16)
0%
|
(17)
-1%
|
(17)
+0%
|
(17)
-2%
|
(19)
-14%
|
(20)
-6%
|
(23)
-13%
|
(25)
-10%
|
(28)
-11%
|
(34)
-21%
|
(38)
-11%
|
(39)
-4%
|
(39)
+2%
|
(39)
-1%
|
(40)
-2%
|
(41)
-3%
|
(41)
-2%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(12)
|
(14)
|
(10)
|
(11)
|
(14)
|
(18)
|
(27)
|
(25)
|
(27)
|
(31)
|
(31)
|
(38)
|
(39)
|
(39)
|
(37)
|
(31)
|
(25)
|
(20)
|
(15)
|
(15)
|
(16)
|
(16)
|
(16)
|
(16)
|
(16)
|
(17)
|
(17)
|
(17)
|
(19)
|
(20)
|
(23)
|
(25)
|
(28)
|
(34)
|
(38)
|
(39)
|
(39)
|
(39)
|
(40)
|
(41)
|
(41)
|
|
Net Income (Common) |
(12)
N/A
|
(14)
-18%
|
(10)
+30%
|
(11)
-10%
|
(14)
-34%
|
(18)
-28%
|
(27)
-50%
|
(25)
+10%
|
(28)
-11%
|
(31)
-11%
|
(31)
0%
|
(38)
-24%
|
(39)
-3%
|
(39)
+1%
|
(37)
+6%
|
(31)
+16%
|
(25)
+19%
|
(20)
+21%
|
(18)
+8%
|
(18)
+3%
|
(19)
-9%
|
(19)
+3%
|
(16)
+13%
|
(17)
-2%
|
(17)
-1%
|
(17)
+1%
|
(20)
-20%
|
(20)
-2%
|
(23)
-12%
|
(24)
-5%
|
(23)
+3%
|
(25)
-10%
|
(28)
-11%
|
(34)
-21%
|
(38)
-11%
|
(39)
-4%
|
(39)
+2%
|
(39)
-1%
|
(40)
-2%
|
(41)
-3%
|
(41)
-2%
|
|
EPS (Diluted) |
-45.57
N/A
|
-53.57
-18%
|
-36.03
+33%
|
-41.15
-14%
|
-55.19
-34%
|
-61.09
-11%
|
-80.7
-32%
|
-62
+23%
|
-76.38
-23%
|
-74.6
+2%
|
-72.88
+2%
|
-90.64
-24%
|
-93.4
-3%
|
-90.62
+3%
|
-85.6
+6%
|
-60.6
+29%
|
-51.93
+14%
|
-25.61
+51%
|
-14.66
+43%
|
-5.13
+65%
|
-8.26
-61%
|
-4.55
+45%
|
-3
+34%
|
-2.85
+5%
|
-2.8
+2%
|
-1.67
+40%
|
-1.37
+18%
|
-0.86
+37%
|
-1.08
-26%
|
-0.63
+42%
|
-0.59
+6%
|
-0.64
-8%
|
-0.73
-14%
|
-0.78
-7%
|
-0.89
-14%
|
-0.92
-3%
|
-0.89
+3%
|
-0.89
N/A
|
-0.9
-1%
|
-0.92
-2%
|
-0.93
-1%
|